Surface layer proteins isolated from Clostridium difficile induce clearance responses in macrophages

Microbes and Infection

Volumn 16, Issue 5, 2014, Pages 391-400

  Collins, Laura E ^a   Lynch, Mark ^a   Marszalowska, Izabela ^a   Kristek, Maja ^a   Rochfort, Keith ^a   O'Connell, Mary ^a   Windle, Henry ^b   Kelleher, Dermot ^b   Loscher, Christine E ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Clostridium difficile; Cytokine; Macrophage; P38; Phagocytosis; Surface layer proteins

Indexed keywords

BACTERIAL PROTEIN; CELL SURFACE MARKER; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SURFACE LAYER PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; MEMBRANE PROTEIN; S-LAYER PROTEINS;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL CLEARANCE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE SYSTEM; IN VITRO STUDY; INFANT; MACROPHAGE MIGRATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RECURRENT INFECTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL MOTION; IMMUNOLOGY; MACROPHAGE; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; SECRETION (PROCESS);

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; MURINAE;

ANIMALS; BACTERIAL PROTEINS; CELL MOVEMENT; CLOSTRIDIUM DIFFICILE; CYTOKINES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MICE; PHAGOCYTOSIS;

EID: 84901618402     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.02.001     Document Type: Article

References (37)

1. Dawson L.F., Valiente E., Wren B.W. Clostridium difficile - a continually evolving and problematic pathogen. Infect Genet Evol 2009, 9:1410-1417.
2. Denève C., Janoir C., Poilane I., Fantinato C., Collignon A. New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 2009, 33:24-28.
3. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
4. Taylor N.S., Thorne G.M., Bartlett J.G. Comparison of two toxins produced by Clostridium difficile. Infect Immun 1981, 34:1036-1043.
5. Chang T.W., Bartlett J.G., Taylor N.S. Clostridium difficile toxin. Pharmacol Ther 1981, 13:441-452.
6. Vohra P., Poxton I.R. Induction of cytokines in a macrophage cell line by proteins of Clostridium difficile. FEMS Immunol Med Microbiol 2012, 65:96-104.
7. Madan R., Jr W.A. Immune responses to Clostridium difficile infection. Trends Mol Med 2012, 18:658-666.
8. Eidhin D.N., Ryan A.W., Doyle R.M., Walsh J.B., Kelleher D. Sequence and phylogenetic analysis of the gene for surface layer protein, slpA, from 14 PCR ribotypes of Clostridium difficile. J Med Microbiol 2006, 55:69-83.
9. Fagan R.P., Albesa-Jové D., Qazi O., Svergun D.I., Brown K.A., Fairweather N.F. Structural insights into the molecular organization of the S-layer from Clostridium difficile. Mol Microbiol 2009, 71:1308-1322.
10. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 1998, 282:2085-2088.
11. Ryan A., Lynch M., Smith S.M., Amu S., Nel H.J., McCoy C.E., et al. A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog 2011, 7:e1002076.
12. Ausiello C.M., Cerquetti M., Fedele G., Spensieri F., Palazzo R., Nasso M., et al. Surface layer proteins from Clostridium difficile induce inflammatory and regulatory cytokines in human monocytes and dendritic cells. Microbes Infect 2006, 8:2640-2646.
13. Calabi E., Calabi F., Phillips A.D., Fairweather N.F. Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect Immun 2002, 70:5770-5778.
14. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
15. Jarchum I., Liu M., Shi C., Equinda M., Pamer E.G. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun 2012, 80:2989-2996.
16. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011, 11:723-737.
17. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
18. Paredes-Sabja D., Cofre-Araneda G., Brito-Silva C., Pizarro-Guajardo M., Sarker M.R. Clostridium difficile spore-macrophage interactions: spore survival. PLoS One 2012, 7:e43635.
19. Ben-Sasson S.Z., Hu-Li J., Quiel J., Cauchetaux S., Ratner M., Shapira I., et al. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci U S A 2009, 106:7119-7124.
20. Lasigliè D., Traggiai E., Federici S., Alessio M., Buoncompagni A., Accogli A., et al. Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients. PLoS One 2011, 6:e20014.
21. Miller L.S., Pietras E.M., Uricchio L.H., Hirano K., Rao S., Lin H., et al. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J Immunol 2007, 179:6933-6942.
22. Ben-Sasson S.Z., Caucheteux S., Crank M., Hu-Li J., Paul W.E. IL-1 acts on T cells to enhance the magnitude of in vivo immune responses. Cytokine 2011, 56:122-125.
23. Bekker L.G., Moreira A.L., Bergtold A., Freeman S., Ryffel B., Kaplan G. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect Immun 2000, 68:6954-6961.
24. Suresh P., Arp L.H. Effect of passively administered immunoglobulin G on the colonization and clearance of Bordetella avium in turkeys. Vet Immunol Immunopathol 1995, 49:229-239.
25. Elkins K.L., Cooper A., Colombini S.M., Cowley S.C., Kieffer T.L. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect Immun 2002, 70:1936-1948.
26. Janeway C.A., Travers P., Walport M., Shlomchik M.J. Immunobiology: the immune system in health and disease 2001, Garland Science, New York.
27. Aderem A., Underhill D.M. Mechanisms of phagocytosis in macrophage. Annu Rev Immunol 1999, 17:593-623.
28. Taylor A.E., Finney-Hayward T.K., Quint J.K., Thomas C.M., Tudhope S.J., Wedzicha J.A., et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010, 35:1039-1047.
29. O'Brien D.K., Melville S.B. The anaerobic pathogen Clostridium perfringens can escape the phagosome of macrophages under aerobic conditions. Cell Microbiol 2000, 2:505-519.
30. O'Brien D.K., Melville S.B. Multiple effects on Clostridium perfringens binding, uptake and trafficking to lysosomes by inhibitors of macrophage phagocytosis receptors. Microbiology 2003, 149:1377-1386.
31. Paredes-Sabja D., Sarker M.R. Interactions between Clostridium perfringens spores and Raw 264.7 macrophages. Anaerobe 2012, 18:148-156.
32. Grosdent N., Maridonneau-Parini I., Sory M.P., Cornelis G.R. Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun 2002, 70:4165-4176.
33. Zhou H., Monack D.M., Kayagaki N., Wertz I., Yin J., Wolf B., et al. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med 2005, 202:1327-1332.
34. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011, 11:762-774.
35. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997, 186:1757-1762.
36. An H., Yu Y., Zhang M., Xu H., Qi R., Yan X., et al. Involvement of ERK, p38 and NF-κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 2002, 106:38-45.
37. Van den Blink B., Juffermans N.P., Ten Hove T., Schultz M.J., Van Deventer S.J., Van der Poll T., et al. p38 Mitogen-activated protein kinase inhibition increases cytokine release by macrophage in vitro and during infection in vivo. J Immunol 2001, 166:582-587.